Riccardo Borroni, MD, PhD, graduated summa cum laude from the University of Pavia, Italy, in 2002. He completed his residency in dermatology and venereology at the Sapienza University of Rome in 2006, after training in skin pathology at the Ackerman Academy of Dermatopathology in New York, USA and at the Medical University of Graz, Austria. From 2008 to 2009 he was visiting fellow at the Pharmacogenomics laboratory of the Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology ETH Zurich, Switzerland. In 2010 he obtained his PhD in Molecular and Regenerative Medicine from the University of Modena and Reggio Emilia, Italy. From 2010 he served as a postdoctoral fellow at the Fondazione IRCCS Policlinico San Matteo in Pavia, Italy. In 2017, he joined Humanitas University as an Assistant Professor, and there he was appointed Associate Professor of Dermatology and Venereology in 2019. Prof. Riccardo Borroni is the recipient of several awards, including the Italian Society of Dermatology and Venereology (SIDeMaST) Fellowship Award in 2008 and in 2009. He authored more than 50 papers on indexed journals and serves as a reviewer for journals in the field of dermatology on a regular basis.
Translational research in dermatology is the main interest of Prof. Borroni, who is currently involved in the preclinical and clinical development of a medical device for the non-invasive diagnosis and monitoring of skin diseases. Prof. Borroni is co-investigator in phase 2 and 3 trials aimed at the development of novel drugs for skin diseases.
- Di Francesco S, Savio M, Bloise N, Borroni RG, Stivala LA, Borroni RG. Red grape (Vitis vinifera L.) flavonoids down-regulate collagen type III expression after UV-A in primary human dermal blood endothelial cells. Exp Dermatol. 2018 Sep;27(9):973-980.
- Borroni RG, Manganoni AM, Grassi S, Grasso M, Diegoli M, Giorgianni C, Favalli V, Pavoni L, Cespa M, Arbustini E. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2AD84V (c.251A>T) mutation in melanoma-prone families from Italy. Melanoma Res. 2017 Apr;27(2):97-103.
- Favalli V, Disabella E, Molinaro M, Tagliani M, Scarabotto A, Serio A, Grasso M, Narula N, Giorgianni C, Caspani C, Concardi M, Agozzino M, Giordano C, Smirnova A, Kodama T, Giuliani L, Antoniazzi E, Borroni RG, Vassallo C, Mangione F, Scelsi L, Ghio S, Pellegrini C, Zedde M, Fancellu L, Sechi G, Ganau A, Piga S, Colucci A, Concolino D, Di Mascio MT, Toni D, Diomedi M, Rapezzi C, Biagini E, Marini M, Rasura M, Melis M, Nucera A, Guidetti D, Mancuso M, Scoditti U, Cassini P, Narula J, Tavazzi L, Arbustini E. Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics. J Am Coll Cardiol. 2016 Sep 6;68(10):1037-50.
- Borroni RG. Role of dermatology in pharmacogenomics: drug-induced skin injury. Pharmacogenomics. 2015;16(4):401-12.
- Lotti R, Marconi A, Truzzi F, Dallaglio K, Gemelli C, Borroni RG, Palazzo E, Pincelli C. A previously unreported function of β1B integrin isoform in caspase-8-dependent integrin-mediated keratinocyte death. J Invest Dermatol. 2010 Nov;130(11):2569-77.